Drug application
ILOPROST (ILOPROST)
Drugs@FDA ANDA 214997 · REGCON HOLDINGS
Key facts
| Drug name | ILOPROST |
|---|---|
| Active ingredients | ILOPROST |
| Application type | ANDA |
| Application number | 214997 |
| Company | REGCON HOLDINGS |
| Dosage forms | SOLUTION, INHALATION |
| Strength | 10MCG/ML (10MCG/ML) |
| Marketing status | Prescription |
| Reference listed drug | No |
| Latest submission status date | Jul 10, 2026 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.